A new trade framework for global healthcare R&D

被引：48

作者：

Hubbard, T ^{[1
]}

Love, J

机构：

[1] Wellcome Trust Sanger Inst, Human Genome Analysis, Hinxton, England

[2] CPTech, Washington, DC USA

来源：

PLOS BIOLOGY | 2004年 / 2卷 / 02期

基金：

英国惠康基金;

关键词：

D O I：

10.1371/journal.pbio.0020052

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：147 / 150

页数：4

共 23 条

[11]

*FAM US, 2003, FAM US PUBL

[12]

HUBBARD TJ, 2003, NEW SCI 0614, P29

[13] Patent buyouts: A mechanism for encouraging innovation [J].

Kremer, M .

QUARTERLY JOURNAL OF ECONOMICS, 1998, 113 (04) :1137-1167

[14]

LOVE J, 2003, TRIPS RIPS BETTER TR

[15]

Love James, 2003, EVIDENCE REGARDING R

[16]

NIHCM (National Institute for Health Care Management Research and Education Foundation), 2002, CHANG PATT PHARM INN

[17] Rewards versus intellectual property rights [J].

Shavell, S ;

Van Ypersele, T .

JOURNAL OF LAW & ECONOMICS, 2001, 44 (02) :525-547

[18] Drugs for neglected diseases:: a failure of the market and a public health failure? [J].

Trouiller, P ;

Torreele, E ;

Olliaro, P ;

White, N ;

Foster, S ;

Wirth, D ;

Pécoul, B .

TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2001, 6 (11) :945-951

[19]

WEISBROD BA, 2003, WASHINGTON POST 0822, pA21

[20]

*WHO, 2003, WORLD HLTH ASS RES, V27

← 1 2 3 →